Effect of Ocrelizumab on Neuroinflammation in Multiple Sclerosis as Measured by 11C-PBR28 MR-PET Imaging of Microglia Activation

Condition:   Multiple Sclerosis Intervention:   Drug: 11C-PBR28 Sponsors:   Massachusetts General Hospital;   Genentech, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials